ten23health is building a new facility in Visp
Share this article
The company plans to establish a new 5,000 m2 manufacturing facility in Visp.
In October 2021, ten23 health acquired a former Swissfillon site to install its production facility. In March 2022, a first 1,000 m2 expansion was announced. The new 5,000 m2 facility will include sterile manufacturing lines plus laboratories, offices and technical areas across four floors.
Ten23 expects construction on the building to be complete by this summer and the production site to be operational by 2024. The project will create around 100 jobs and allow the company to add around 30 million units in annual filling capacity.
In this new plant, the company plans to add two factory lines that will operate in synergy with the existing one in Visp, and the development and testing services for sterile products in Basel.
ten23 health is based in Basel and supports its clients in developing differentiated, stable, usable, and safe injectable treatments for patients.